Clinical Trial

Dipotassium Oxalate for Postoperative Sensitivity in NCCLs

Study acronym: DIPOX-RCT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Postoperative sensitivity is a common complication following Class V composite restorations, particularly in non-carious cervical lesions (NCCLs). This randomized controlled trial aims to evaluate the effectiveness of dipotassium oxalate as a pre-treatment agent in reducing postoperative sensitivity. A total of 64 participants will be randomly assigned into two groups: an intervention group receiving dipotassium oxalate prior to adhesive application, and a control group receiving standard adhesive protocol without pretreatment. Sensitivity will be assessed using a Visual Analog Scale (VAS) in response to cold and air stimuli at baseline, 24 hours, 7 days, and 30 days. The study aims to determine whether dipotassium oxalate significantly reduces postoperative sensitivity and can be incorporated into routine restorative dental practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-13.
Trial Details
NCT Number NCT07540299
Lead Sponsor Postgraduate Medical Institute, Lahore
Conditions Dentin Hypersensitivity, Post Operative Sensitivity Control
Enrollment 64 participants
Start Date 2026-06-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22